Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...

In addition to impaired insulin secretion, type 2 diabetic patients also have elevated levels of glucagon, which worsens hyperglycemia by increasing glucose production by the liver. Type 2 ...

By inhibiting DPP4, vildagliptin causes an increase in glucagon like peptide-1 (GLP-1), an intestinal hormone that aids in glucose homeostasis and insulin secretion. The manufacturer of ...

The incretins include the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) that trigger insulin secretion and regulate blood glucose homeostasis. CCK and GLP-1 ...

GLP-1, an incretin hormone secreted by intestinal L cells in response to food intake, enhances glucose-dependent insulin secretion, suppresses glucagon release, and delays gastric emptying ...

Next, Yeung wanted to determine how this toxin affected glucagon secretion in rodent tissue. She conducted experiments on tissues, such as the rat pancreas and mouse pancreatic islets. Her experiments ...

and glucagon-like peptide-1 (GLP-1). GLP-1 is in the same family of hormones as NPF—they're both called incretins because they can increase the secretion of insulin. There has been an explosion ...

Glucose-dependent insulinotropic polypeptide (GIP) stimulates the secretion of glucagon under lower plasma glucose concentrations, thereby aiding glycemic management. Although research suggests ...